Materials and methods for treating hypercholesterolemia

C - Chemistry – Metallurgy – 07 – C

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07C 69/675 (2006.01) A61K 31/47 (2006.01) A61K 31/505 (2006.01) A61P 3/06 (2006.01) C07C 69/708 (2006.01) C07C 69/732 (2006.01) C07D 207/34 (2006.01) C07D 209/10 (2006.01) C07D 209/12 (2006.01) C07D 209/24 (2006.01) C07D 213/30 (2006.01) C07D 213/55 (2006.01) C07D 213/80 (2006.01) C07D 215/14 (2006.01) C07D 239/42 (2006.01) C07D 307/80 (2006.01) C07D 311/72 (2006.01)

Patent

CA 2492906

The subject invention provides novel HMG-CoA-reductase inhibitors. In a preferred embodiment, the HMG-CoA reductase inhibitors of the subject invention can be deactivated to a primary inactive metabolite by hydrolytic enzymes. Compounds of the present invention can be advantageously used to treat patients suffering hypercholesterolemia.

La présente invention concerne de nouveaux inhibiteurs de L'HMG-CoA réductase. Dans un mode préféré de l'invention, les inhibiteurs de l'HMG-CoA réductase présentés peuvent être désactivés en un métabolite inactif primaire par des enzymes hydrolytiques. Les composés selon la présente invention peuvent être utilisés de façon avantageuse pour traiter des patients souffrant d'hypercholestérolémie.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Materials and methods for treating hypercholesterolemia does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Materials and methods for treating hypercholesterolemia, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Materials and methods for treating hypercholesterolemia will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1958586

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.